Cancer Research Targets  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heckl, S.
Right arrow Articles by Braun, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heckl, S.
Right arrow Articles by Braun, K.
[Cancer Research 62, 7018-7024, December 1, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

CNN-Gd3+ Enables Cell Nucleus Molecular Imaging of Prostate Cancer Cells: The Last 600 nm

Stefan Heckl1, Jürgen Debus, Jürgen Jenne, Rüdiger Pipkorn, Waldemar Waldeck, Herbert Spring, Ralf Rastert, Claus W. von der Lieth and Klaus Braun

Department of Oncological Diagnostics and Therapy, German Cancer Research Center, Heidelberg, Germany [S. H.]; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany [J. D., J. J., R. R., K. B.]; Central Section for Peptide Synthesis, German Cancer Research Center, Heidelberg, Germany [R. P.]; Division Organisation of Complex Genomes, German Cancer Research Center, Heidelberg, Germany [H. S.]; Division Biophysics of Macromolecules, German Cancer Research Center, Heidelberg, Germany [W. W.]; and Central Section for Spectroscopy, German Cancer Research Center, Heidelberg, Germany [C. W. v. d. L.]

Molecular imaging is defined as the characterization and measurement of biological processes at the cellular and molecular level. Molecular imaging, therefore, necessitates a sufficient amount of contrast agent within the cell. Consequently, we realized that the intracellular uptake and cell compartment specificity of the commonly used interstitial contrast agent gadolinium (Gd3+) with a cell-nucleus directed peptide module could be helpful. This modular molecule is characterized by a Gd3+-complex module that is bound to a transmembrane transport unit (TPU) of human origin and further to a nucleus-directed address module (nuclear localization sequence) resulting in a specific cell nucleus-directed nuclear localization sequence-conjugated Gd3+-complex (CNN-Gd3+-complex). By use of magnetic resonance imaging, Gd3+ was detected within DU-145 prostate cancer cells after only 10 min. The nuclear localization was confirmed with confocal laser scanning microscopy. The resulting MRI signal enhancement only slightly decreased over the next 48 h compared with an absolute loss of signal enhancement after only 8 h when a random target sequence was used. Therefore, our method seems promising for in vivo application in molecular imaging.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Heckl and U. Vogel
Nuclear Trafficking of a Gadolinium Conjugate in Nude Mice Xenografted with Human LN-229 Glioma
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 657 - 662.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.